Type 1 diabetes immunotherapy: is the glass half empty or half full? Read more about Type 1 diabetes immunotherapy: is the glass half empty or half full?
Leveraging crowdsourcing to facilitate the discovery of new medicines. Read more about Leveraging crowdsourcing to facilitate the discovery of new medicines.
A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice. Read more about A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice.
Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment. Read more about Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment.
Therapeutic targeting of SPINK1-positive prostate cancer. Read more about Therapeutic targeting of SPINK1-positive prostate cancer.
Personalized prostate cancer screening: improving PSA tests with genomic information. Read more about Personalized prostate cancer screening: improving PSA tests with genomic information.
PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors. Read more about PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors.
A microbe-dependent viral key to Crohn's box. Read more about A microbe-dependent viral key to Crohn's box.
Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Read more about Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.
Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness. Read more about Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness.
